CIC
MXCT icon

Chilton Investment Company’s MaxCyte MXCT Stock Holding History

Chilton Investment Company’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-21,933
Closed -$103K – 193
2023
Q4 		$103K Hold
21,933
– – ﹤0.01% 169
2023
Q3 		$68.4K Buy
+21,933
New +$88.2K ﹤0.01% 166

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Chilton Investment Company's MXCT Position: Q1 2024 in Review

Chilton Investment Company sold out of MaxCyte (MXCT) in Q1 2024, closing a stake of 21,933 shares — an estimated $103K sold.

Chilton Investment Company first reported a position in MXCT in Q3 2023 and held it in 2 quarters. The position peaked at $103K in Q4 2023. 123 funds tracked by Wall St. Rank hold MXCT as of Q1 2024.

  • Chilton Investment Company reported no remaining MaxCyte position as of Q1 2024 after selling out during the quarter.
  • Chilton Investment Company sold 21,933 MaxCyte shares in Q1 2024, an estimated $103K.
  • Chilton Investment Company first reported a position in MaxCyte in Q3 2023 and held it in 2 quarters.
  • Chilton Investment Company's MaxCyte position peaked at $103K in Q4 2023.
  • 123 funds tracked by Wall St. Rank held MaxCyte as of Q1 2024.

Based on Chilton Investment Company's 13F filing for Q1 2024, filed 15 May 2024.